[go: up one dir, main page]

TR200302130T4 - 4-Amino-6,7-Demetoksi-2- (5-Metansulfonamido-1,2,3,4-Tetrahidroisokinol-2-İl) -5-(2-Piridil) Kinazolin Mesilat ve Polimorflar - Google Patents

4-Amino-6,7-Demetoksi-2- (5-Metansulfonamido-1,2,3,4-Tetrahidroisokinol-2-İl) -5-(2-Piridil) Kinazolin Mesilat ve Polimorflar

Info

Publication number
TR200302130T4
TR200302130T4 TR2003/02130T TR200302130T TR200302130T4 TR 200302130 T4 TR200302130 T4 TR 200302130T4 TR 2003/02130 T TR2003/02130 T TR 2003/02130T TR 200302130 T TR200302130 T TR 200302130T TR 200302130 T4 TR200302130 T4 TR 200302130T4
Authority
TR
Turkey
Prior art keywords
tetrahydroisoquinol
methanesulfonamido
pyridyl
amino
demethoxy
Prior art date
Application number
TR2003/02130T
Other languages
English (en)
Inventor
Ann Basford Patricia
Blaise Hodgson Paul
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005200A external-priority patent/GB0005200D0/en
Priority claimed from GB0015900A external-priority patent/GB0015900D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of TR200302130T4 publication Critical patent/TR200302130T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Mevcut bulus formül (I)'in 4-amino-6,7-dimetoksi-2- (5-metansulfonamido-1,2,3,4-tetrahidroisokinol-2-il) -5-(2-piridil) kinazolin mesilati ile birlikte bunu hazirlama islemleri ve onu içeren kompozisyonlari saglar. Bulus ayrica serbest bazin temel olarak saf susuz kristal polimorfik biçimleri ile de ilgilidir. Bilesimler özellikle habis prostatik hiperplasia tedavisinde yararlidir.
TR2003/02130T 2000-03-03 2001-02-23 4-Amino-6,7-Demetoksi-2- (5-Metansulfonamido-1,2,3,4-Tetrahidroisokinol-2-İl) -5-(2-Piridil) Kinazolin Mesilat ve Polimorflar TR200302130T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0005200A GB0005200D0 (en) 2000-03-03 2000-03-03 New salt form
GB0015900A GB0015900D0 (en) 2000-06-28 2000-06-28 New salt form

Publications (1)

Publication Number Publication Date
TR200302130T4 true TR200302130T4 (tr) 2004-01-21

Family

ID=26243792

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/02130T TR200302130T4 (tr) 2000-03-03 2001-02-23 4-Amino-6,7-Demetoksi-2- (5-Metansulfonamido-1,2,3,4-Tetrahidroisokinol-2-İl) -5-(2-Piridil) Kinazolin Mesilat ve Polimorflar

Country Status (40)

Country Link
US (1) US6683085B2 (tr)
EP (1) EP1268468B1 (tr)
JP (1) JP3857919B2 (tr)
KR (1) KR100496089B1 (tr)
CN (1) CN1214029C (tr)
AP (1) AP2002002611A0 (tr)
AR (1) AR029482A1 (tr)
AT (1) ATE253570T1 (tr)
AU (1) AU779118B2 (tr)
BG (1) BG106869A (tr)
BR (1) BR0108910A (tr)
CA (1) CA2398963C (tr)
CR (1) CR6731A (tr)
CZ (1) CZ20022858A3 (tr)
DE (1) DE60101157T2 (tr)
DK (1) DK1268468T3 (tr)
EA (1) EA004748B1 (tr)
EE (1) EE200200496A (tr)
ES (1) ES2208565T3 (tr)
GE (1) GEP20043364B (tr)
HK (1) HK1053655A1 (tr)
HN (1) HN2001000036A (tr)
HR (1) HRP20020718A2 (tr)
HU (1) HUP0300006A3 (tr)
IL (1) IL150634A0 (tr)
IS (1) IS6441A (tr)
MA (1) MA26876A1 (tr)
MX (1) MXPA02008665A (tr)
NO (1) NO20024195L (tr)
NZ (1) NZ519672A (tr)
OA (1) OA12186A (tr)
PE (1) PE20011225A1 (tr)
PL (1) PL365070A1 (tr)
PT (1) PT1268468E (tr)
SI (1) SI1268468T1 (tr)
SK (1) SK12282002A3 (tr)
TN (1) TNSN01034A1 (tr)
TR (1) TR200302130T4 (tr)
UA (1) UA72311C2 (tr)
WO (1) WO2001064672A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163696B2 (en) 2001-10-11 2007-01-16 Pfizer Inc. Pharmaceutical formulations
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
DE10223913A1 (de) * 2002-05-29 2003-12-11 Bayer Cropscience Ag Verfahren zur Herstellung spezifischer Kristallmodifikationen polymorpher Substanzen
GB0221582D0 (en) * 2002-09-17 2002-10-23 Pfizer Ltd Method of treatment
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2005089804A2 (en) * 2004-03-16 2005-09-29 Pfizer Limited Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists
CN101584696A (zh) * 2008-05-21 2009-11-25 上海艾力斯医药科技有限公司 包含喹唑啉衍生物的组合物及制备方法、用途
CN105596301A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914114A (en) 1984-05-28 1990-04-03 Merck Patent Gesellschaft Mit Breschrankter Haftung 3-[4-(4-phenyl-1,2,3,6-tetrahydro-1-pyridyl)butyl]-5-hydroxy-indole methanesulfonate having sedating and anti-parkinsonism properties
JPH0822859B2 (ja) * 1986-09-16 1996-03-06 メルク・パテント・ゲゼルシヤフト ミツト・ベシユレンクテル・ハフツング ヒドロキシインドール誘導体
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
DE60101157D1 (de) 2003-12-11
HN2001000036A (es) 2001-07-09
NO20024195D0 (no) 2002-09-03
JP2003525289A (ja) 2003-08-26
CN1432010A (zh) 2003-07-23
KR20020080463A (ko) 2002-10-23
TNSN01034A1 (fr) 2005-11-10
EE200200496A (et) 2004-02-16
HUP0300006A2 (en) 2003-05-28
KR100496089B1 (ko) 2005-06-17
DK1268468T3 (da) 2004-02-09
MXPA02008665A (es) 2003-02-24
BG106869A (bg) 2002-12-29
HUP0300006A3 (en) 2006-01-30
EP1268468B1 (en) 2003-11-05
CA2398963C (en) 2006-10-24
PL365070A1 (en) 2004-12-27
EP1268468A1 (en) 2003-01-02
NZ519672A (en) 2004-06-25
WO2001064672A1 (en) 2001-09-07
SK12282002A3 (sk) 2003-10-07
JP3857919B2 (ja) 2006-12-13
PE20011225A1 (es) 2001-12-08
NO20024195L (no) 2002-09-03
CA2398963A1 (en) 2001-09-07
HK1053655A1 (en) 2003-10-31
IS6441A (is) 2002-06-25
GEP20043364B (en) 2004-03-10
OA12186A (en) 2006-05-09
IL150634A0 (en) 2003-02-12
US20020010188A1 (en) 2002-01-24
UA72311C2 (uk) 2005-02-15
PT1268468E (pt) 2004-01-30
ES2208565T3 (es) 2004-06-16
MA26876A1 (fr) 2004-12-20
US6683085B2 (en) 2004-01-27
CR6731A (es) 2004-03-11
EA200200826A1 (ru) 2003-02-27
HRP20020718A2 (en) 2004-02-29
AU779118B2 (en) 2005-01-06
BR0108910A (pt) 2002-12-24
CN1214029C (zh) 2005-08-10
ATE253570T1 (de) 2003-11-15
SI1268468T1 (en) 2004-04-30
DE60101157T2 (de) 2004-09-02
AR029482A1 (es) 2003-07-02
AP2002002611A0 (en) 2002-09-30
EA004748B1 (ru) 2004-08-26
CZ20022858A3 (cs) 2003-09-17
AU3588801A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
DK1000035T3 (da) Substituerede 6-phenylphenanthridiner
ATE270278T1 (de) Phthalazinone pde iii/iv hemmer
TR199903270T2 (tr) Omeprazol sodyum tuzu.
HUP0105077A2 (hu) Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
UA85698C2 (ru) Хинолиновые промежуточные соединения для синтеза ингибиторов рецепторной тирозинкиназы и способ их получения
ATE305787T1 (de) 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
DE60205776D1 (en) Indolinon-derivative als protein-kinasehemmer
DK1597239T3 (da) Polymorf af {6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3E)
TR200102138T2 (tr) (S)-Omeprazolün potasyum tuzu.
TR200302130T4 (tr) 4-Amino-6,7-Demetoksi-2- (5-Metansulfonamido-1,2,3,4-Tetrahidroisokinol-2-İl) -5-(2-Piridil) Kinazolin Mesilat ve Polimorflar
DE60228098D1 (de) Pyridin-substituierte furanderivate als raf-kinase inhibitoren
PL362766A1 (en) Novel imidazole derivatives, production method thereof and use thereof
DE60015599D1 (de) 3,4-DIHYDRO-(1H)CHINAZOLIN-2-ON-VERBINDUNGEN ALS CSBP/p38-KINASE-INHIBITOREN
CY1106713T1 (el) Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες
DK1273572T3 (da) Thiophensubstituerede piperaziner anvendelige til behandling af binign prostatisk hyperplasi
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
MXPA04001977A (es) Antagonistas v de receptor ccr-3.
UY26604A1 (es) Nueva forma de sal y polimorfos
CO5221124A1 (es) Nueva forma de sal y polimorfos
DE60143023D1 (de) Tumorhemmende nitroacridin-zusammensetzungen
IS7179A (is) Lyfjafræðilegar samsetningar til leysnistýringar á 4-amínó-6,7-dímetoxý-2-(5-metansúlfónamídó-1,2,3,4,-tetrahýdróísókínól-2-ýl)-5-(2-pýridýl) kínasólíni
DK0869957T3 (da) 3(2H)-Pyridazinonderivater og farmaceutiske sammensætninger indeholdende disse forbindelser
DE60120398D1 (de) Imidazopyridin-8-one
DK1286965T3 (da) Piperidin-forbindelser og fremgangsmåder til fremstilling af sådanne